#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13888	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2017	681.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1684	1684	T	698	T,C	654,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13888	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2017	681.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	768	C,T	718,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	0	.	n	.	0	C1005T	SNP	1005	1005	C	1415	1415	T	779	T,C,G	742,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1747	1747	A	833	A,G	790,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2381	2381	C	838	C	789	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2455	2455	A	809	A,C	775,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3007	3007	C	799	C	758	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25552	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3683	692.4	0	HET	.	.	.	C1642T	.	1642	1642	C	2052	2052	C	827	C,T	608,172	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	130728	blaTEM	861	861	100.0	blaTEM.l15.c17.ctg.1	1765	5047.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2136	folP	855	855	99.77	folP.l15.c4.ctg.1	1518	140.1	0	.	p	.	0	A81V	NONSYN	241	243	GCG	546	548	GTG	183;184;188	G;T;G	176;162;176	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2136	folP	855	855	99.77	folP.l15.c4.ctg.1	1518	140.1	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	990	992	AGC	210;211;211	A;G;C	200;202;201	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5476	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	161.2	1	SNP	p	S91F	1	.	.	271	273	TTC	536	538	TTC	213;213;212	T;T;C	204;204;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5476	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	161.2	1	SNP	p	D95G	1	.	.	283	285	GGC	548	550	GGC	210;207;208	G;G;C	197;194;196	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5476	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	161.2	1	SNP	p	G95N	0	.	.	283	285	GGC	548	550	GGC	210;207;208	G;G;C	197;194;196	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1720	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1470	116.6	1	SNP	p	G45D	0	.	.	133	135	GGC	538	540	GGC	216;219;220	G;G;C	205;207;208	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	804	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1124	71.3	0	.	n	.	0	A197.	DEL	197	197	A	636	636	A	184	A	174	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	0	.	p	.	0	E91G	NONSYN	271	273	GAG	681	683	GGG	203;203;203	G;G,A;G	193;195,1;197	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	1	SNP	p	D86N	0	.	.	256	258	GAC	666	668	GAC	197;199;199	G;A;C	186;184;189	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	1	SNP	p	S87R	0	.	.	259	261	AGT	669	671	AGT	200;197;201	A,C;G;T	190,1;187;189	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	1	SNP	p	S87I	0	.	.	259	261	AGT	669	671	AGT	200;197;201	A,C;G;T	190,1;187;189	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	1	SNP	p	S87W	0	.	.	259	261	AGT	669	671	AGT	200;197;201	A,C;G;T	190,1;187;189	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4856	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3128	154.8	1	SNP	p	S88P	0	.	.	262	264	TCC	672	674	TCC	202;202;202	T;C;C	193;191;192	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4456	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2778	159.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1587	1589	GGC	236;233;234	G;G;C	220;215;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	236;237;234	G;C;A	224;222;222	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	232;232;231	A;T;C	220;223;218	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	237;236;236	G;T;G	230;229;232	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	237;236;236	G;T;G	230;229;232	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	194;194;196	A;C,T;C	177;180,1;186	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1809	1811	GCG	186;183;184	G;C,G;G	173;145,1;156	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1809	1811	GCG	186;183;184	G;C,G;G	173;145,1;156	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1932	1934	GGC	144;140;144	G;G;C	135;134;142	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	148;144;145	G;G;C,G	141;135;137,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3950	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2352	167.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1959	1961	CTG	137;137;139	C,G;T;G,C	113,3;110;119,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5396	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3312	162.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1767	1769	CCG	221;220;220	C;C;G	203;209;202	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2588	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1806	142.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	517	517	C	184	C	173	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	310	35.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	163	165	ACG	64;63;60	A;C;G	58;57;56	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	310	35.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	205	207	CAA	26;24;23	C;A;A	24;22;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	264	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	310	35.5	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	211	213	TAC	16;14;13	T;A;C	15;12;13	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	A26T	NONSYN	76	78	GCC	230	232	ACC	206;206;206	A;C;C	188;194;194	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	D41K	NONSYN	121	123	GAC	275	277	AAA	212;215;212	A;A;A,C	204;207;204,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	512	514	AAG	214;214;219	A;A;G	206;205;209	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	D121G	NONSYN	361	363	GAC	515	517	GGC	213;212;210	G;G;C	203;205;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	797	799	GCT	205;207;207	G;C;T	198;201;199	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	P219S	NONSYN	655	657	CCC	809	811	TCC	210;211;211	T;C;C	203;205;204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2730	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1346	198.4	0	.	p	.	0	A256T	NONSYN	766	768	GCA	920	922	ACA	216;216;217	A;C;A	200;201;204	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9948	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4900	202.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1967	1969	AAT	208;210;206	A;A;T	196;196;192	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1202	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	997	119.0	1	SNP	p	V57M	1	.	.	169	171	ATG	448	450	ATG	233;232;235	A;T;G	223;221;222	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	9654	tetM	1920	1920	100.0	tetM.l6.c30.ctg.1	2541	378.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
